Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $41.1M | $45.2M | $45.5M | $65.4M | $79.9M | $100.0M |
| Revenue growth | — | 9.8% | 0.7% | 43.7% | 22.1% | 25.1% |
| Gross profit | $30.3M | $33.4M | $32.5M | $48.1M | $59.1M | $77.2M |
| Gross margin | 73.6% | 74.0% | 71.4% | 73.6% | 73.9% | 77.2% |
| Operating income | -$13.1M | -$23.7M | -$40.8M | -$27.2M | -$21.7M | -$16.3M |
| Operating margin | -31.7% | -52.5% | -89.6% | -41.5% | -27.1% | -16.3% |
| Net income | -$24.3M | -$36.1M | -$47.1M | -$33.0M | -$27.1M | -$21.5M |
| Net margin | -59.0% | -79.9% | -103.4% | -50.4% | -34.0% | -21.5% |
| EPS (diluted) | -$117.85 | -$2.17 | -$1.91 | -$1.27 | -$0.93 | -$0.66 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$21.6M | -$24.6M | -$36.9M | -$19.7M | -$17.9M | -$11.0M |
| Capital expenditures | $62.0K | $384K | $603K | $173K | $306K | $332K |
| Free cash flow | -$21.7M | -$25.0M | -$37.5M | -$19.9M | -$18.3M | -$11.3M |
| Share buybacks | — | — | — | — | $0.00 | $49.5M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $26.4M | $19.2M | $6.61M | $18.1M | $13.4M | $21.7M |
| Total assets | $56.0M | $134M | $114M | $108M | $94.6M | $106M |
| Total liabilities | $62.4M | $60.1M | $79.3M | $87.0M | $86.6M | $86.5M |
| Long-term debt | $50.8M | $49.8M | $52.9M | $57.0M | $59.5M | $58.9M |
| Shareholders' equity | -$148M | $73.5M | $34.8M | $20.7M | $8.01M | $19.0M |
| Retained earnings | -$388M | -$424M | -$471M | -$504M | -$531M | -$552M |
| Shares (wtd avg diluted) | 204K | 16.6M | 24.6M | 25.9M | 29.1M | 32.7M |
Every figure is extracted from NeuroPace Inc’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.